Dyslipidemia
Dyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardial infarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control.As part of the Oxford American Cardiology Library…
Mehr
CHF 39.35
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Cannon, Christopher P. (Hrsg.)
- ISBN: 978-0-19-978037-2
- EAN: 9780199780372
- Produktnummer: 13998918
- Verlag: Oxford University Press
- Sprache: Englisch
- Erscheinungsjahr: 2011
- Plattform: PDF
- Masse: 937 KB
Über den Autor
Ragavendra R. Baliga, MD, MBA, FACC, FRCP, is Director of Cardiovascular Medicine at The Ohio State University Medical Center in Columbus, Ohio.Christopher P. Cannon, MD, is Associate Professor of Medicine at Harvard Medical School and Associate Physician, Cardiovascular Division, at Brigham and Women's Hospital in Boston, Massachusetts.
13 weitere Werke von Ragavendra R. (Hrsg.) Baliga:
Bewertungen
Anmelden